福瑞股份(300049) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 reached ¥269,976,553.36, representing a 26.81% increase compared to the same period last year[6]. - Net profit attributable to shareholders for Q3 2022 was ¥28,214,642.45, a significant increase of 76.96% year-over-year[6]. - The net profit after deducting non-recurring gains and losses for Q3 2022 was ¥28,443,206.15, up 91.87% from the previous year[6]. - The company's basic earnings per share for Q3 2022 was ¥0.1073, an increase of 77.94% compared to the same period last year[6]. - Total operating revenue for the current period reached ¥719,049,123.81, an increase of 19.7% compared to ¥600,305,316.55 in the previous period[36]. - Net profit for the current period was ¥95,800,886.56, representing a 16.5% increase from ¥82,242,918.86 in the previous period[38]. - Basic earnings per share increased to ¥0.2310 from ¥0.2250, reflecting a growth of 2.2%[42]. Assets and Liabilities - The total assets as of the end of Q3 2022 were ¥2,437,235,242.09, reflecting a decrease of 3.46% from the end of the previous year[6]. - The company's total liabilities as of September 30, 2022, were CNY 638.11 million, down from CNY 718.97 million at the beginning of the year, indicating a reduction of about 11.2%[31]. - As of September 30, 2022, the company's total assets amounted to approximately CNY 2.44 billion, a decrease from CNY 2.52 billion at the beginning of the year[30]. - The company's cash and cash equivalents decreased to CNY 347.59 million from CNY 472.72 million at the beginning of the year, representing a decline of approximately 26.4%[30]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 18,532[16]. - The largest shareholder, Wang Guan Yi, holds 11.31% of the shares, equating to 29,754,138 shares[16]. - China National Investment High-tech Industry Investment Co., Ltd. holds 6.93% of the shares, totaling 18,240,000 shares[16]. - New Yu Fu Chuang Investment Co., Ltd. owns 6.04% of the shares, amounting to 15,886,000 shares[16]. - The total number of restricted shares at the beginning of the period was 32,398,266, with 44,450 shares released during the period, leaving 32,353,816 restricted shares at the end[22]. - Wang Guan Yi has 22,315,603 restricted shares, which will be released at a rate of 25% annually[19]. Cash Flow and Investments - The cash flow from operating activities for the year-to-date period was ¥109,000,962.13, down 19.18% year-over-year[6]. - The company experienced a 95% decrease in cash received from investment due to reduced minority shareholder contributions[15]. - The company incurred share-based payment expenses of CNY 20.80 million for the first three quarters of 2022 due to the implementation of the employee stock ownership plan[29]. - Cash flow from financing activities resulted in a net cash outflow of -207,658,400.75, compared to -7,009,504.51 in the previous period, indicating increased financial strain[44]. - Cash paid for dividends and interest was 160,809,712.11, significantly higher than 21,210,043.42 in the previous period, indicating increased shareholder returns[44]. Research and Development - Research and development expenses increased by 31% to ¥52,028,613.67 due to higher investment by the French subsidiary[12]. - Research and development expenses rose to ¥52,028,613.67, up 31.2% from ¥39,652,726.97 in the prior period[36]. Project Development - The company is continuing the construction of the Furu Health Technology Park project, with support from the local government[23]. - The project was previously at risk due to land use rights recovery but has now been supported for continuation[24].